SCHEMBL458992

SCHEMBL458992

CCCCCCCCCCCCCCCC(=O)NC(CCC)(C(=O)[O-])[N+](C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46
HSP90AA1 P07900 1/20 0.43
CPT2 P23786 1/20 0.43
CPT1A P50416 1/20 0.43
CPT1B Q92523 1/20 0.43
FAAH O00519 4/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
GRK2 P25098 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CES2 O00748 3/20 0.40
CES1 P23141 3/20 0.40
MAPK1 P28482 1/20 0.40
FABP3 P05413 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1309808 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL3720030 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL459434 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL139532 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL420549 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL43085 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL418327 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL1311278 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL1310843 1.00 ALDH1A1 (0.47) ALDH1A1HRH3HSP90AA1CPT2CPT1A
SCHEMBL1309574 0.98 ALDH1A1 (0.49) ALDH1A1HRH3HSP90AA1CPT2CPT1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118215507-A Lyophilized ENPP1 polypeptide formulations and uses thereof 依诺兹梅制药公司 2024-06-18 CN claimed
EP-3220741-B1 COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME ROCHAL IND LLC (US) 2021-02-24 EP claimed
EP-1391193-B1 Silicone-in-water emulsion comprising specific polyether-polydimethylsiloxane copolymer BEIERSDORF AG (DE) 2007-01-03 EP claimed
US-20040044077-A1 Agents for inhibiting or restoring skin damage caused by drying and method for evaluating the same SHISEIDO COMPANY, LTD. (JP) 2004-03-04 US claimed
EP-1011624-B1 PHOTOPROTECTANT COSMETIC COMPOSITION CONTAINING AN ANIONIC SURFACTANT, COMPOSITIONS FILTERING ULTRAVIOLET RADIATION AND AN AMPHIPHILIC CATIONIC OR DIPOLAR ION COMPOUND AND ITS USE OREAL (FR) 2003-11-12 EP claimed
EP-1354580-A1 AGENTS FOR INHIBITING OR RESTORING SKIN DAMAGE CAUSED BY DRYING AND METHOD OF EVALUATING THE SAME SHISEIDO COMPANY LIMITED (JP) 2003-10-22 EP claimed
CN-118340881-A Pharmaceutical composition comprising anti-IL-5 antibodies and uses thereof 广东恒瑞医药有限公司 2024-07-16 CN disclosed
WO-2024146630-A1 METHOD FOR TREATING ASTHMA BY USING TSLP ANTIBODY 江苏恒瑞医药股份有限公司 2024-07-11 WO disclosed
WO-2024140903-A1 COMPOSITION OF CD40-BINDING MOLECULE AND PHARMACEUTICAL USE THEREOF 苏州盛迪亚生物医药有限公司 2024-07-04 WO disclosed
WO-2024135543-A1 COMPOSITION COMPRISING MODIFIED STARCH, C13-C15 FATTY ACID, AND POWDERY ORGANIC SALT L'OREAL (FR) 2024-06-27 WO disclosed
WO-2024135424-A1 COMPOSITION COMPRISING HYALURONIC ACID-BASED POLYION COMPLEX AND HYDROPHILIC OR LIPOPHILIC ANTIOXIDANT L'OREAL (FR) 2024-06-27 WO disclosed
WO-2024114626-A1 ANTI-HER3 ANTIBODY-DRUG CONJUGATE COMPOSITION AND PHARMACEUTICAL USE THEREOF 苏州盛迪亚生物医药有限公司 2024-06-06 WO disclosed
WO-2024088293-A1 COMPOSITION COMPRISING ANTI-MASP2 ANTIBODY, AND PHARMACEUTICAL USE 江苏恒瑞医药股份有限公司 2024-05-02 WO disclosed
EP-1466959-A1 Aqueous compositions containing anionic and cationic surfactants for obtaining a yield point Goldschmidt AG (DE) 2004-10-13 EP disclosed
EP-1464322-A1 Use of compositions containing a chosen fluorescent dye and a chosen amphoteric or nonionic surfactant for dyeing human kerateous fibres with a bleaching effect L'OREAL (FR) 2004-10-06 EP disclosed
US-20040115150-A1 Cosmetics and treatment method for promoting maturation of cornified envelopes SHISEIDO COMPANY, LTD. (JP) 2004-06-17 US disclosed
US-20040044077-A1 Agents for inhibiting or restoring skin damage caused by drying and method for evaluating the same SHISEIDO COMPANY, LTD. (JP) 2004-03-04 US disclosed
EP-1374832-A1 COSMETICS TO PROMOTE MATURATION OF CORNIFIED ENVELOPE AND METHOD FOR TREATMENT SHISEIDO COMPANY, LTD. (JP) 2004-01-02 EP disclosed
EP-1354580-A1 AGENTS FOR INHIBITING OR RESTORING SKIN DAMAGE CAUSED BY DRYING AND METHOD OF EVALUATING THE SAME SHISEIDO COMPANY LIMITED (JP) 2003-10-22 EP disclosed
US-5336446-A Mixture of anionic surfactant salts and N-substituted betaines GOODMAN ROBERT M (US) 1994-08-09 US disclosed